STING agonists as next-generation vaccine adjuvants: mechanisms, opportunities, and challenges

Current Opinion in Virology · Published 2026-05-01 · DOI 10.1016/j.coviro.2026.101543

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.coviro.2026.101543

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Beyond the liver: the broadened tissue tropism of hepatitis E virus · Current Opinion in Virology · 2026 · Same journal
• Molecular dialogues in plant rhabdovirus–host interactions · Current Opinion in Virology · 2026 · Same journal
• New directions in the multifunctionality of RNA viruses: insights from the rabies virus P-protein · Current Opinion in Virology · 2025 · Same journal
• Orthobunyavirus entry: receptors, endocytosis, and fusion cues · Current Opinion in Virology · 2026 · Same journal
• Respiratory syncytial virus (RSV) and influenza A virus (IAV) interplay with the type I and III interferon (IFN) responses in the respiratory epithelium · Current Opinion in Virology · 2026 · Same journal
• Virological and immunological determinants of hepatitis E virus infection outcomes · Current Opinion in Virology · 2025 · Same journal
• Beyond brain fog: viral proteins as convergent drivers of neuroinflammation and proteinopathy · Current Opinion in Virology · 2026 · Same journal
• Inborn errors of autophagy underlying severe viral infections in humans · Current Opinion in Virology · 2026 · Same journal
• A storm is born: immune activation and pathogenesis in arthritogenic alphavirus infections · Current Opinion in Virology · 2025 · Same journal
• Use of age-specific human in vitro platforms to advance discovery and development of novel vaccine adjuvants · Current Opinion in Virology · 2026 · Same journal